MedTrace Logo

The WeACT Program for Family Caregivers of People Living With Dementia

NCT07342569 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether WeACT, a self-paced, web-based program, is feasible and helpful for adult family caregivers of a relative living with dementia. WeACT is based on acceptance and commitment therapy (ACT), which teaches skills to handle difficult thoughts and feelings and take steps toward what matters most.

The main questions this study aims to answer are:

* Can caregivers complete WeACT as planned?
* Do caregivers show improvements in mental health and coping after using WeACT?
* What are caregivers' experiences with the program, and what suggestions do they have to improve it?

Participants will:

* Complete six self-paced weekly online modules and use the daily practice section during the program.
* Complete online questionnaires before starting and after completing the program.
* Take part in one online interview about their experience.

Conditions

Interventions

BEHAVIORAL

WeACT

WeACT includes six self-paced weekly ACT modules and a tailored daily practice component. Each weekly module includes ACT skills training materials. The daily practice section provides brief, in-the-moment ACT skill coaching based on participants' current self-ratings.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • Areum Han · University of South Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07342569 on ClinicalTrials.gov